Secondary stroke prevention: An update
Professor Nathan Bornstein discusses risk factors and treatment options for secondary stroke.
Professor Bornstein has received consultation fees from Pfizer, Ever Neuro Pharma and Shire. He has received lecture bureau from Boehringer Ingelheim, Novonordisk and Sanofi Aventis.